Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort
2009

Tryptophan Degradation in Irritable Bowel Syndrome

Sample size: 36 publication Evidence: moderate

Author Information

Author(s): Clarke Gerard, Fitzgerald Peter, Cryan John F, Cassidy Eugene M, Quigley Eamonn M, Dinan Timothy G

Primary Institution: University College Cork

Hypothesis

Is tryptophan degradation altered in male patients with irritable bowel syndrome compared to healthy controls?

Conclusion

The study found that tryptophan degradation is enhanced in male IBS patients, suggesting a potential immune-mediated mechanism.

Supporting Evidence

  • Kynurenine levels were significantly higher in IBS patients compared to controls.
  • Neopterin levels were also elevated in IBS patients, indicating immune activation.
  • The kynurenine:tryptophan ratio was increased in IBS patients, suggesting enhanced tryptophan degradation.

Takeaway

This study shows that men with irritable bowel syndrome have higher levels of certain substances related to tryptophan breakdown, which might help understand their condition better.

Methodology

Plasma samples were analyzed for tryptophan and its metabolites using high performance liquid chromatography (HPLC) and neopterin levels were measured with an ELISA assay.

Potential Biases

The reliance on a male-only sample may not represent the broader IBS population, which is predominantly female.

Limitations

The study was limited to a small male cohort and could not analyze differences based on IBS symptom types.

Participant Demographics

26 healthy male controls (mean age 32.2) and 10 male IBS patients (mean age 47.5).

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-230X-9-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication